Epidemic Shiga Bacillus Dysentery in Central America. I. Etiologic Investigations in Guatemala, 1969

scientific article published on September 1, 1970

Epidemic Shiga Bacillus Dysentery in Central America. I. Etiologic Investigations in Guatemala, 1969 is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/INFDIS/122.3.170
P953full work available at URLhttp://academic.oup.com/jid/article-pdf/122/3/170/3052388/122-3-170.pdf
P698PubMed publication ID4915510

P50authorArmando CaceresQ68149947
Leonardo J. MataQ109797136
P2093author name stringE. J. Gangarosa
M. L. Mejicanos
D. R. Perera
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectGuatemalaQ774
epidemicQ44512
P304page(s)170-180
P577publication date1970-09-01
P1433published inJournal of Infectious DiseasesQ4051141
P1476titleEpidemic Shiga Bacillus Dysentery in Central America. I. Etiologic Investigations in Guatemala, 1969
P478volume122

Reverse relations

cites work (P2860)
Q36957798An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine
Q73312589An outbreak of Shiga bacillus dysentery in KwaZulu/Natal, South Africa
Q45087869Antibiotic resistance of Shigella strains isolated in the Federal Republic of Germany 1989-1990.
Q46639481Antimicrobial resistance and serotypes of Shigella isolates in Kigali, Rwanda (1983 to 1993): increasing frequency of multiple resistance
Q33936849Antimicrobial resistance in the tropics
Q43309801Batch process solar disinfection is an efficient means of disinfecting drinking water contaminated with Shigella dysenteriae type I.
Q93192095Burden of laboratory-confirmed shigellosis infections in Guatemala 2007-2012: results from a population-based surveillance system
Q36461093Characterization of an R-Plasmid Associated with Ampicillin Resistance in Shigella dysenteriae Type 1 Isolated from Epidemics
Q40581944Cholera El Tor in Latin America, 1991-1993.
Q36844719Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road
Q36194407Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1.
Q35754969Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens
Q39498427Comparison of sucrose with glucose in oral therapy of infant diarrhoea
Q37343213Diagnostic value of indirect hemagglutination in the seroepidemiology of Shigella infections
Q28744352Dipstick test for rapid diagnosis of Shigella dysenteriae 1 in bacterial cultures and its potential use on stool samples
Q33877398Dr. Kiyoshi Shiga: discoverer of the dysentery bacillus
Q41812066Drug resistance and plasmid profile of shigellae in Taiwan
Q36444089Enteric infections and the vaccines to counter them: future directions
Q54292516Epidemic shiga dysentery in Central America.
Q36504937Epidemiology of shigellosis in Teknaf, a coastal area of Bangladesh: a 10-year survey
Q40481471Gender perceptions predict sex differences in growth patterns of indigenous Guatemalan infants and young children.
Q33686643Genomic analysis of the emergence of 20th century epidemic dysentery.
Q39306485Global phylogeography and evolutionary history of Shigella dysenteriae type 1.
Q36505352High level resistance to trimethoprim, cotrimoxazole and other antimicrobial agents among clinical isolates of Shigella species in Ontario, Canada--an update
Q48818354INCAP studies of nutrition and infection
Q37167794Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections
Q39429450Immunomagnetic separation and PCR detection show Shigellae to be common faecal agents in children from urban marginal communities of Costa Rica
Q34828010Importation of Shiga bacillus dysentery into California. Clinical and public health significance
Q50688240Incidence of multiple antibiotic resistances in organisms isolated from cases of infantile diarrhoea in a Nigerian oral rehydration therapy clinic.
Q55393967Isolation of Shigella species and their resistance patterns to a panel of fifteen antibiotics in mid and far western region of Nepal.
Q54640033Letter: Ampicillin-resistant Shiga bacillus in Bangladesh.
Q39388407Letter: Transfer of ampicillin resistance from Shigella dysenteriae type 1 to Escherichia coli
Q35598035Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit
Q35266183Magnitude of drug resistant shigellosis in Nepalese patients
Q40691166Microbial development of drug resistance: mechanisms and clinical significance
Q46693238Multi-gene amplification: simultaneous detection of three virulence genes in diarrhoeal stool
Q36472443Occurrence of multiple antibiotic resistance and R plasmids in Enterobacteriaceae isolated from children in the Sudan
Q36675006Oral rehydration and maintenance of children with rotavirus and bacterial diarrhoeas
Q46799503Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 DeltaicsA Deltaent Deltafep DeltastxA:HgR oral vaccine SC599 in healthy human adult volunteers.
Q30403500Plasmid analysis of Shigella dysenteriae type 1 isolates obtained from widely scattered geographical locations
Q45230483Plasmid characterisation in the investigation of an epidemic caused by multiply resistant Shigella dysenteriae type 1 in Central Africa
Q42148303Plasmid characterization of drug-resistant Shigella dysenteriae 1 from an epidemic in Central Africa
Q36505004Plasmid profile analysis and antimicrobial susceptibility patterns of Shigella isolates from Nigeria
Q36504991Plasmid profiles of antibiotic-resistant Shigella dysenteriae types 2, 3, 4, 6 and 7 isolated in Ethiopia during 1976-85.
Q42258091Plasmid-determined antibiotic resistance in Shigella flexneri isolated in England and Wales between 1974 and 1978
Q44235396Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1.
Q37339622Prevalence of Shigella serogroups and their antimicrobial resistance patterns in southern Trinidad
Q40230921Quantitative microtiter cytotoxicity assay for Shigella toxin.
Q33725239Randomized trial of high- and low-dose ampicillin therapy for treatment of severe dysentery due to Shigella dysenteriae type 1
Q93697809Science and non-science in psychiatry
Q69254226Serum enterotoxin-neutralizing antibody in human shigellosis
Q93754902Shiga bacillus dysentery complicated by bacteremia and disseminated intravascular coagulation
Q30371964Shigella dysenteriae type 1 infections in US travellers to Mexico, 1988.
Q42045506Shigella dysenteriae type 1--severe dysentery and sepsis with hematologic, hepatic and renal complications
Q36258170Shigella species from Addis Ababa: frequency of isolation and in vitro drug sensitivity
Q34019305Shigella: A Highly Virulent and Elusive Pathogen
Q43325908Shigellosis in Mozambique: the 1993 outbreak rehabilitation--a follow-up study
Q36448762Shigellosis in the south-western Cape of Good Hope 1968-85.
Q47901479Spontaneous tandem amplification and deletion of the shiga toxin operon in Shigella dysenteriae 1.
Q34000330Strategy for cross-protection among Shigella flexneri serotypes
Q35651224The genome of Shigella dysenteriae strain Sd1617 comparison to representative strains in evaluating pathogenesis
Q34069456The pathogenesis of Shigella diarrhea. I. Enterotoxin production by Shigella dysenteriae I.
Q36506214The prevalence and genetics of resistance to commonly used antimicrobial agents in faecal Enterobacteriaceae from children in Bangladesh
Q40853204The threat of multiresistant microorganisms
Q33269861Using European travellers as an early alert to detect emerging pathogens in countries with limited laboratory resources
Q35119483Virulence versus resistance
Q36505152Waterborne transmission and the evolution of virulence among gastrointestinal bacteria
Q68916401Widal-type serology using live antigen for diagnosis of Shigella flexneri dysentery

Search more.